Development of HIV medicines. The unit engages in the research and development of HIV medicines and performing pre-clinical trials and set discovery phases.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb (HIV R&D assets)‘s full profile, request access.
Request a free trial